Emphysema Research Registry and Biosample Repository

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age21+
SponsorUniversity of Pittsburgh

About this trial

The Comprehensive Lung Center (CLC) at the University of Pittsburgh Medical Center (UPMC Health System) provides patients with any type of breathing or lung disorder a full range of diagnostic and therapeutic services. The Emphysema/COPD Research Center (ECRC) is a specialty clinic, within this center, that attempts to advance the understanding of emphysema and to evaluate new therapies for patients with emphysema. The Emphysema Research Registry will enable pulmonary research physicians to: 1) gather information and create a research registry of people who have been diagnosed with emphysema; 2) utilize this research registry with the purpose of conducting research that attempts to advance the understanding of emphysema and to evaluate new therapies; and, 3) use the research registry to identify potential candidates for future research programs. These aims will be achieved by the collection of DNA (genetic material)for analysis and storage in addition to pulmonary function tests and other medical information.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Patients would be required to have COPD based on at least one of the following: clinical history, pulmonary function results, or radiographic results.

Disqualifiers

none

Trial population

Current and former smokers with a 10 pack year tobacco history.

Trial design

Design model

Cohort

Time perspective

Other

Treatments tested in this trial

Not listed

Trial groups

3,000 Participants
are grouped into 1 trial group
Group A: Registry

Trial outcomes

Primary outcomes

1

To gather information and create a research registry of people who have been diagnosed with emphysema and a control cohort of research participants without lung diseases,

This research registry will allow us to to advance the understanding of emphysema and to evaluate new therapies for patients with emphysema.

Time frame
Indefinite

Secondary outcomes

1

To continue communications with past, present, and future research participants.

To utilize this research registry with the purpose to learn more about the pathogenesis of emphysema and the efficacy of new therapies, and to provide a mechanism for improving the quality of treatment for emphysema and advance the field.

Time frame
Indefinite

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.